- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4098EUR$4,500USD£3,524GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3187EUR$3,500USD£2,741GBP
- Report
- December 2021
Global
From €4417EUR$4,850USD£3,798GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1366EUR$1,500USD£1,175GBP
- Report
- October 2024
Global
From €3187EUR$3,500USD£2,741GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2504EUR$2,750USD£2,154GBP
The Rhinovirus Test is a type of infectious disease test used to detect the presence of the rhinovirus, a common cause of the common cold. The test is typically used to diagnose a current infection or to determine if a person has been exposed to the virus in the past. It is often used in combination with other tests to diagnose respiratory illnesses. The test is typically performed using a nasal swab or a throat swab, and the results are usually available within a few days.
The Rhinovirus Test market is a subset of the larger Infectious Disease Testing market, which is estimated to be worth billions of dollars. The market is expected to grow in the coming years due to the increasing prevalence of infectious diseases and the need for more accurate and timely diagnosis.
Some companies in the Rhinovirus Test market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more